Literature DB >> 3819258

Visual field limitation in the patient with dementia of the Alzheimer's type.

R Steffes, J Thralow.   

Abstract

This paper investigates the existence of a visual field limitation and its effect on the advanced Alzheimer's patient. The data presented was obtained by testing 12 Alzheimer's and 12 control patients. The control patients were demented from causes secondary to reasons other than Alzheimer's disease. The results indicated that patients demented due to Alzheimer's have visual field losses significantly greater than other demented patients. This significant visual loss is of importance in assisting in differential diagnosis, performing patient cares, and planning patient environments.

Entities:  

Mesh:

Year:  1987        PMID: 3819258     DOI: 10.1111/j.1532-5415.1987.tb02309.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  5 in total

1.  Driving and dementia California's approach to a medical and policy dilemma.

Authors:  D B Reuben; P St George
Journal:  West J Med       Date:  1996-02

2.  Visual impairment and cognitive dysfunction in Alzheimer's disease.

Authors:  R F Uhlmann; E B Larson; T D Koepsell; T S Rees; L G Duckert
Journal:  J Gen Intern Med       Date:  1991 Mar-Apr       Impact factor: 5.128

3.  [Disabilities and impairment in activities of daily living as possible risk factors in dementia: prospective study in Basel 1986].

Authors:  M Eichholzer; S Christeller; J Thurneysen; H Stähelin
Journal:  Soz Praventivmed       Date:  1992

4.  Ophthalmologic Psychophysical Tests Support OCT Findings in Mild Alzheimer's Disease.

Authors:  Elena Salobrar-Garcia; Rosa de Hoz; Blanca Rojas; Ana I Ramirez; Juan J Salazar; Raquel Yubero; Pedro Gil; Alberto Triviño; José M Ramirez
Journal:  J Ophthalmol       Date:  2015-05-27       Impact factor: 1.909

5.  Dementia and driving.

Authors:  D O'Neill; K Neubauer; M Boyle; J Gerrard; D Surmon; G K Wilcock
Journal:  J R Soc Med       Date:  1992-04       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.